Search alternatives:
small decrease » small increased (Expand Search)
Showing 2,301 - 2,320 results of 2,520 for search '(( ((aromatic decrease) OR (dramatic decrease)) ) OR ( small decrease ))', query time: 0.24s Refine Results
  1. 2301

    Table 6_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx by Meiling Liu (390553)

    Published 2025
    “…This study aimed to analyze the microRNA (miRNA) profile of cerebrospinal fluid (CSF) in NB patients to identify potential biomarkers for NB diagnosis.</p>Methods<p>Small RNA sequencing was utilized to identify differential expressed miRNAs (DEmiRNAs) in CSF samples from both control and NB patients (in-house cohort). …”
  2. 2302

    Video 3_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…The study has some limitations: small animal number, lack of long-term follow-up, and the outcome is limited to only one parameter, CBPI. …”
  3. 2303

    Data Sheet 1_Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.docx by Dagny Førde (20452325)

    Published 2025
    “…Different miRs are frequently dysregulated and implicated in the development and outcome of non-small cell lung cancer (NSCLC). We investigated the prognostic and functional aspects of miR-17-5p and miR-20a-5p by.…”
  4. 2304

    <i>DANCR</i> regulated genes in SK-MEL-28 cells. by Stephanie M. E. Jones (12883691)

    Published 2025
    “…<i>DANCR</i> is a multi-exonic, cytoplasmically-enriched lncRNA and small RNA host gene transcribed from syntenic regions in the human and zebrafish genomes. …”
  5. 2305

    Table 1_Reconstructing Holocene centennial cooling events: synthesized temperature changes, chronology, and forcing in the Northern Hemisphere.xlsx by Sergey A. Gorbarenko (13696381)

    Published 2024
    “…However, the sequence of HCCEs 3b, 3a, and 2b (over 4.53–3.42 BP), accompanied by small changes in the TSI, was likely forced by an increase in ENSO variability, leading to remarkable changes in the tropical processes and a southward shift of the ITCZ, coeval with the collapse of the Chinese Neolithic cultures and onset of the Holocene Neoglacial. …”
  6. 2306

    Supplementary Material for: Inhalant Allergen Sensitization: Prevalence, Risk Factors, and Geographic Variation in the United States by figshare admin karger (2628495)

    Published 2025
    “…Across allergen sources, males had higher prevalence (from lowest to highest: 25.3% mold/fungi to 43.0% dust mite) compared to females (from lowest to highest: 16.1% mold/fungi to 34.6% dust mite); prevalence peaked in 10-19 years (from lowest to highest: 29.7% mold/fungi to 54.2% dust mite) and then decreased with increasing age; large metropolitan areas (from lowest to highest: 39.6% dust mite to 20.7% mold/fungi) had higher prevalence compared to small-to-medium metro (from lowest to highest: 36.6% dust mite to 17.9% mold/fungi) or nonmetro areas (from lowest to highest: 32.4% dust mite to 19.5% mold/fungi); a higher prevalence was observed in patients with asthma, atopic dermatitis, or rhinitis than in those with none of these diagnoses reported. …”
  7. 2307

    Table 5_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx by Meiling Liu (390553)

    Published 2025
    “…This study aimed to analyze the microRNA (miRNA) profile of cerebrospinal fluid (CSF) in NB patients to identify potential biomarkers for NB diagnosis.</p>Methods<p>Small RNA sequencing was utilized to identify differential expressed miRNAs (DEmiRNAs) in CSF samples from both control and NB patients (in-house cohort). …”
  8. 2308

    Table1_Treatment of refractory immune-mediated necrotizing myopathy with efgartigimod.docx by MengTing Yang (19925814)

    Published 2024
    “…</p>Conclusions<p>Despite its small size, our study demonstrated that promoting the degradation of endogenous immunoglobulin G may be effective for patients with IMNM. …”
  9. 2309

    Data Sheet 1_Reconstructing Holocene centennial cooling events: synthesized temperature changes, chronology, and forcing in the Northern Hemisphere.docx by Sergey A. Gorbarenko (13696381)

    Published 2024
    “…However, the sequence of HCCEs 3b, 3a, and 2b (over 4.53–3.42 BP), accompanied by small changes in the TSI, was likely forced by an increase in ENSO variability, leading to remarkable changes in the tropical processes and a southward shift of the ITCZ, coeval with the collapse of the Chinese Neolithic cultures and onset of the Holocene Neoglacial. …”
  10. 2310

    Image 1_Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity.tif by Michael J. Clowers (15165896)

    Published 2025
    “…</p>Methods<p>Here, we tested the anti-tumor and early immunotherapeutic efficacy of TTI-101, a selective small-molecule inhibitor of canonical STAT3 signaling, in a K-ras<sup>G12D</sup> mutant lung cancer mouse model (CC-LR).…”
  11. 2311

    Table 1_The benefit of fodder legumes as dairy feeding source for reducing greenhousegas emissions of modelled farms.docx by Karin Weggler (21669608)

    Published 2025
    “…Fodder production is the third major source of GHG emission in dairy production. The use of small seeded legumes as major fodder could possibly reduce this source of GHG emissions. …”
  12. 2312

    Data Sheet 1_Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity.pdf by Michael J. Clowers (15165896)

    Published 2025
    “…</p>Methods<p>Here, we tested the anti-tumor and early immunotherapeutic efficacy of TTI-101, a selective small-molecule inhibitor of canonical STAT3 signaling, in a K-ras<sup>G12D</sup> mutant lung cancer mouse model (CC-LR).…”
  13. 2313

    Video 1_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…The study has some limitations: small animal number, lack of long-term follow-up, and the outcome is limited to only one parameter, CBPI. …”
  14. 2314

    Presentation 1_Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients.pptx by Alain Gelibter (6409364)

    Published 2024
    “…<p>Pembrolizumab (an anti-PD1 antibody) alone or combined with chemotherapy represented the standard of care for advanced non-oncogene addicted non-small cell lung cancer (NSCLC) patients. These therapies induced early modifications of the immune response impacting the clinical outcome. …”
  15. 2315

    Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel by Satoshi Kaneda (571209)

    Published 2025
    “…Aquatic oligochaetes extracted from a Tottori station soil were visually divided into three categories: large, medium, and small specimens. Four mustard concentrations of 0.05, 0.2, 0.5, and 2 g L<sup>−1</sup> were prepared, and 10 oligochaetes comprising three large, four medium, and three small individuals were submerged into each concentration at 15°C, then observed for 2 h. …”
  16. 2316

    Data Sheet 1_The N6-methyladenosine RNA epigenetic modification modulates the amplification of coxsackievirus B1 in human pancreatic beta cells.pdf by Maressa Fernandes Bonfim (6700379)

    Published 2024
    “…Here we show that the N6-methyladenosine (m6A) RNA epigenetic modification machinery regulates CVB1 amplification in the human beta cells. Using small interfering RNA (siRNA) targeting m6A writers and erasers, we observed that downregulation of m6A writers increases CVB1 amplification, while the downregulation of m6A erasers decreases it. …”
  17. 2317

    Image 1_Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.jpeg by Essha Chatterjee (9400908)

    Published 2025
    “…We evaluated its anticancer activity in non-small cell lung cancer (NSCLC), using A549 adenocarcinoma cells as the primary model.…”
  18. 2318

    Image 2_The N6-methyladenosine RNA epigenetic modification modulates the amplification of coxsackievirus B1 in human pancreatic beta cells.tif by Maressa Fernandes Bonfim (6700379)

    Published 2024
    “…Here we show that the N6-methyladenosine (m6A) RNA epigenetic modification machinery regulates CVB1 amplification in the human beta cells. Using small interfering RNA (siRNA) targeting m6A writers and erasers, we observed that downregulation of m6A writers increases CVB1 amplification, while the downregulation of m6A erasers decreases it. …”
  19. 2319

    Image 3_Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo.jpeg by Essha Chatterjee (9400908)

    Published 2025
    “…We evaluated its anticancer activity in non-small cell lung cancer (NSCLC), using A549 adenocarcinoma cells as the primary model.…”
  20. 2320

    Image 3_The N6-methyladenosine RNA epigenetic modification modulates the amplification of coxsackievirus B1 in human pancreatic beta cells.tif by Maressa Fernandes Bonfim (6700379)

    Published 2024
    “…Here we show that the N6-methyladenosine (m6A) RNA epigenetic modification machinery regulates CVB1 amplification in the human beta cells. Using small interfering RNA (siRNA) targeting m6A writers and erasers, we observed that downregulation of m6A writers increases CVB1 amplification, while the downregulation of m6A erasers decreases it. …”